Board of Directors

 

Jeremy D. Ollerenshaw, Ph.D. is Founder and Executive Director of the Neurobiology Foundation. Dr. Ollerenshaw obtained his Ph.D. in 1989 from the University of Leicester in the UK and has worked in academic research and in the biotechnology industry in the United States for more than twenty years. He has received significant research funding from a number of international sources and has over 50 published peer-reviewed manuscripts and abstracts that have been presented at international conferences and in scientific and clinical literature. In addition, Dr. Ollerenshaw has authored a number of book chapters covering clinical and biochemical research. He has had a strong interest in psychopharmacology and its relationship to serious mental illness for many years.

Susan H. Yarbrough, CCMEP. Sits on the board of directors of the Neurobiology Foundation. Susan began her career in continuing medical education in 2001 at a research institute within a community hospital in Atlanta, Georgia. Prior to that, Susan served in a number of project management roles in the non-profit arena and state government. After a decade in the continuing medical education field, Susan currently serves as the Regulatory Manager for prIME Oncology, a medical education company based in Atlanta, Georgia. Her volunteer activities include serving as President of the Georgia Aliance for CME, a committee member on the Aliance for CME’s State and Regional Committee, and as an Accreditation Council for Continuing Medical Education (ACCME) surveyor. Susan was also among the first in her field to successfully earn the CCMEP certificate. Her extracurricular actvites include reading, running and cooking.

.

Kirby S. Black, Ph.D. sits on the Board of Directors of the Neurobiology Foundation and has more than 30 years of experience in medical product development in industry and academia. He was Senior Vice President of Research and Development at CryoLife, Inc. (NYSE:CRY), Co-Founder, Vice President and COO of AuraZyme Pharmaceuticals, Director of Medical Information at Advanced Tissue Sciences and Presedent and CEO of Epix Pharmaceuticals. His fields of expertize include cardiac, vascular, orthopaedic, tissue engineering, allograft tissue transplantation, anti-cancer therapy, tissue sealants and glues, enzyme replacement and antibody-drug conjugates. He has a doctorate in Immunology and Cell Biology from the University of California, Irvine and BSME from UCLA.

 

HarveyShuster_152_softHarvey Shuster sits on the Board of Directors of the Neurobiology Foundation and is COO for Emergence – Georgia Medical Accelerator. Harvey is a CPA and MBA with over 30 years experience building emerging growth and starting technology companies, operating a medical software company, as well as consulting to the largest organizations to build their own successful ventures. He has worked with medical companies through co-founding and leading the Southeastern Medical Device Association (SEMDA) in 2004. The companies he helped start and raised funds for included the well-known Peachtree Software. As a successful serial entrepreneur, Harvey operated the eLearning pioneer company working with companies like AT&T, IBM, Microsoft and Verizon as well as others. In this, the Bell South (AT&T) eLearning division was started by him with 35 direct reports. He saved Bell South over $1 million per year. Harvey has extensive experience in a number of areas through his leadership of Bell South’s eLearing division, including: obtaining continuing sales deals, using financial controls, operating companies more productively, creating new products, and raising funds. He worked for PWC (Coopers & Lybrand) in IT consulting and audit and has built relationships at the highest levels with organizations such as AT&T, Ford Motor Company, IBM Corp, Microsoft PWC, Verizon and Whirlpool. Harvey serves on the Boards of: The Southeastern Software Association (SSA – which he co-founded), Emergence – Georgia Medical Accelerator, and the Technology Forum of The Greater North Fulton Chamber of Commerce. He co-founded the Southeastern Medical Device Association (SEMDA) with John Yates, and served on SEMDA committees for the annual conference, where he was chair of venture capital group and moderator of The VC panel. Harvey holds a BS in Accounting from Temple University, and an MBA in Finance from Drexel University.

Dr Wood Headshot

James H. Wood, MD. sits on the Board of Directors and is also one of the Neurobiology Foundation’s Scientific Advisors. Dr. Wood received his M.D. degree from Johns Hopkins University School of Medicine in 1973.  He completed his surgical internship at the Duke University Medical Center.  Then he was chosen to serve as Clinical Associate of the Surgical Neurology Branch of NINCDS at the National Institutes of Health from 1974-1976 where he continued his clinical and basic neuroscience research.  From 1976-1981, Dr. Wood completed his neurosurgery residency at the University of Pennsylvania during which time he edited two textbooks, Neurobiology of Cerebrospinal fluid ( 1 & 2). He became Board Certified by the American Board of Neurological Surgery in 1983.

Dr. Wood then served as Assistant Professor of Neurosurgery at Emory University School of Medicine from 1981-1986 and as Clinical Associate Professor of Neurosurgery at the Medical College of Georgia from 1987-1997. He was honored to be Visiting Professor at Harvard Medical School, University of Tennessee School of Medicine, University of Cincinnati School of Medicine and Medical College of South Carolina.  He went on to edit monographs on carotid artery surgery, mood disorders and neurotransmitters. He was Director of the Emory University Hospital Cerebral Blood Flow Laboratory from 1981-1986 and served on the editorial board of the journal Neurosurgery from 1987-1988. He has published over 110 articles and chapters in peer reviewed medical journal and textbooks.

Dr. Wood went into the private practice of neurosurgery in 1986. He was elected Chief of Surgery at the West Paces Medical Center (HCA) in 1996 and served on that hospital’s Board of Trustees.  He served as President-Elect, President and Past President of the Medical Staff at Atlanta Medical Center (Tenet Healthcare) from 2007-2012. He is certified by the American College of Surgeons for disaster management and emergency preparedness. From 2012-2015, he served as Chief Medical Officer at Piedmont Medical Center (Tenet Healthcare) in Rock Hill, SC. and Chairman of the Advisory Board of the medical device company, Surgitrac Corporation (www.surgitrac.com).

Dr. Wood is currently Advisor and minority owner of CareOneTeam Transition Care and Chronic Disease Management (www.CareOneTeam.com) and Advisor of the programmatic advertising company, VuKnowledge Media  (www.vuknowledge.com).

 

Robert Poole bio picture_sRobert Poole sits on the Board of Directors of the Neurobiology Foundation. With over 30 years of corporate workforce development experience, Robert currently serves as Director of Business Development for Emory University’s Continuing Education. In that role, Robert works with Atlanta area companies to identify and deliver training initiatives that improve workforce performance.

Robert holds a Master Degree in Adult Learning & Leadership from Columbia University, and has been accepted into Mercer University’ PhD in Higher Educational Leadership.  In addition to serving on the Board of Neurobiology Foundation, Robert also currently serves on the Advisory Board of Emergence, an incubator for start-up companies in Health IT, the Board of Advisors of Technology Association of Georgia (TAG) Health, and Sub-committee Chair with the Greater North Fulton Chamber of Commerce’s Workforce Development initiative.

 

Andrew_headhsotAndrew Fleshner, MBA, MCTS, cPhT. sits on the Board of Directors of the Neurobiology Foundation.  Andrew has over 25 years experience in sales, marketing, and business development and has worked in senior management with a diverse portfolio of private, public, and non-profit organizations.  He has worked with medical device companies since 2000 and was involved in launching five novel medical devices in cardiology, otolaryngology, and gynecology. His background includes a bachelor’s degree in economics from the University of Georgia and a master’s degree in business administration from Kennesaw State University.

………………………………………………………………………………………………………………………………………………………………………………………………

michelle_pic2_152_soft_lgMichelle Castillo sits on the Board of Directors of the Neurobiology Foundation. Michelle is currently the Head of Competitive Intelligence for Baxter Healthcare.  Prior to her tenure at Baxter, Michelle was a highly successful Strategy Consultant focused on the pharma, device, and healthcare market segments for consultancies such as Kantar/The Mattson Jack Group.  Michelle’s experience also includes the successful start-up of Decision Analyst’s healthcare consulting business unit focused on strategic market analyses for the pharma and medical device industries.  Michelle has over 20 years of industry experience with depth knowledge of numerous therapeutic categories, including extensive commercialization development within the neurosciences. Michelle holds a BS from Columbia College and an MBA from Baylor University.

………………………………………………………………………………………………………………………………………………………………………………………………..

Robert_pic_152wRobert Derricotte  sits on the Board of Directors of the Neurobiology Foundation. He launched Medical Marketing Insights in January 2008. MMI is a leading Atlanta management consulting firm specializing in the pharmaceutical and biotech industry with focus on business development, licensing, clinical and sales strategy. Robert recently launched, co-founded and is president of the Georgia Bioscience Commercialization Center in Atlanta, a non-profit organization helping entrepreneurs and inventors start life science companies. As a consultant, he was VP, Business Development at EquaChem supporting drug reformulation and liposome drug delivery technology. Robert is also co-founder of Healthcare First, a CME accredited medical education company. Robert’s career in the pharmaceutical industry has included assignments at UCB Pharma, Pharmacia and GD Searle supporting dermatology compounds (Olux & Luxiq), the US Celebrex business, Ambien and  opportunities in the cardiovascular market where he successfully launched Covera-HS, a second generation Calan SR. Robert holds a BA in Communications from Southern Illinois University, and an MBA from The Lake Forest Graduate School of Management in Chicago.

 

KenSorensenHS_br_lg_ptKen Sorensen, Ph.D. sits on the Board of Directors of the Neurobiology Foundation. Ken is Head of Healthcare Investment Banking with Halcyon Cabot Partners. Prior to joining Cabot, Dr. Sorensen was the founder and managing partner of Array Capital Management, LLC, a life sciences focused merchant bank. Prior to founding Array Capital, Dr. Sorensen worked for M & Co., a New York based investment firm, where he managed a Crossover Life Sciences Fund, Ariane Health. He was also lead manager for a number of biotechnology financings and mergers and acquisitions that included Ontogeny, Netgenics, Physiome and Avalon Pharmaceuticals. Dr. Sorenson’s scientific credentials include dual bachelor’s degrees in biology from the University of Kansas, a Ph.D.  in Developmental Neurobiology from the University of Arizona and numerous scientific publications. Dr. Sorenson has worked as a research scientist at the Salk Institute in La Jolla where he was an Amgen and a Damon Runyon Fellow, conducting independent  research in brain development. After the Salk Institute D. Sorensen served at the US Patent Office in Washington, D.C. as a Patent Examiner in the Biotechnology Division and serving on the EST Commission, a policy steering body for patenting issues surrounding the Human Genome Project. He has successfully completed the Federal Bar Exam and is a registered Patent Agent.

………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………..